AVENTURA, Fla., Oct. 26, 2011 /PRNewswire/ -- ONE Bio, Corp.
("ONE" or the "Company") (OTC BB: ONBI), an innovative company
utilizing green process manufacturing to produce raw chemicals and
herbal extracts, natural and health supplements and organic
products, today announced it has appointed BDO USA, LLP ("BDO") as its new independent
auditor.
BDO has been engaged to perform the Company's (including its
China and Canada subsidiaries) quarterly reviews and
annual audit. With 41 offices in the
United States, offices in China and over 1,000 BDO offices in more than
100 countries worldwide, BDO is uniquely positioned to provide to
the Company the necessary SEC expertise and credibility.
Marius Silvasan, ONE's CEO,
stated, "BDO's depth and breadth of knowledge and international
expertise as a top auditing firm will provide further credibility
to our financials particularly in view of recent market concerns
over the filings for certain companies with operations in
China. We are pleased to have BDO
as our auditor and look forward to a successful working
relationship. I would also like to take this opportunity to thank
JSW our former auditor for their work and support."
About ONE Bio, Corp.
ONE Bio, Corp. ("ONE") (OTC BB: ONBI) (www.onehcorp.com),
headquartered in Miami, FL, is an
innovative company utilizing patented green process manufacturing
to produce raw chemicals and herbal extracts, natural supplements
and organic products. ONE is focused on the Asia Pacific region and the United States. Key products include widely
recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic
fertilizers, and organic bamboo health food and beverages. ONE has
experienced solid organic growth driven by a robust demand for its
products in China, Japan and the United
States.
This press release includes statements that constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE
Bio, Corp. claims the protection of the safe-harbor for
forward-looking statements contained in the Reform Act. These
forward-looking statements are often characterized by the terms
"may," "believes," "projects," "expects," or "anticipates," and do
not reflect historical facts. Specific forward-looking statements
contained in this press release include, but are not limited to:
our successful integration of diversified growth companies, impact
of the company's expansion plan, and new business development
success, future financial results, development and acquisition of
new product lines and services, the impact of competitive products
or pricing from technological changes, the effect of economic
conditions and other uncertainties. The forward-looking statements
contained herein involve risks and uncertainties that could cause
actual results to differ materially from the expectations contained
in any such forward-looking statements. These risks include, but
are not limited to: failure to manage operating expenses or
integrate new companies and/or technologies, each of which could
have a material impact on our business, our financial results, and
the company's stock price. These risks and other factors are
detailed in the Company's regular filings with the U.S. Securities
and Exchange Commission. Most of these factors are difficult to
predict accurately and are generally beyond the Company's control.
Forward-looking statements speak only as to the date they are made
and ONE Bio, Corp. does not undertake to update forward-looking
statements to reflect circumstances or events that occur after the
date the forward-looking statements are made.
Company Contact:
Marius Silvasan
CEO
Tel. + 786-288-3488
Email: msilvasan@onehcorp.com
Investor Relations Contact:
Investor Relations & Corporate Communications
Tel. +888-676-4445
Email: ir@onehcorp.com
SOURCE ONE Bio, Corp.